BioSpace News Archive

• The Australian launch of VivaGel® BV (Fleurstat BVgel) is the first launch globally with further launches to follow in Europe and other regions • Fleurstat BVgel (VivaGel® BV) is marketed in Australia by Aspen • VivaGel® BV is an Australian innovation – a non-antibiotic therapy – which addresses a global unmet medical need

Dr. Campion is a highly experienced biotech and pharmaceutical professional, bringing more than 20 years of experience in the industry.

Bernstein Liebhard LLP announced that only 6 weeks remain to make a motion for lead plaintiff in a securities class action lawsuit alleging claims on behalf of those who purchased the securities of American Renal Associates Holdings, Inc. between August 10, 2016 and March 27, 2019, both dates inclusive.

The agreement supports a vision of personalized healthcare to Qatar’s population and beyond

The Company’s previously announced process to appoint a new Chair is ongoing.

RM LAW, P.C. announces that a class action lawsuit has been filed on behalf of all persons or entities that purchased Care.com, Inc. between March 27, 2015 and April 1, 2019, inclusive.

For the past 13 years, Novus Health has helped organizations and their employees, members and customers navigate the complex health care systems around the world.

The company will host a conference call beginning at 4:30 p.m. ET / 1:30 p.m. PT the same day to review results and provide a business update.

CPhI data predicts India to be one of the world’s ‘fastest growing bio’ hubs in 2019, fuelled by new biosimilars production

New iclaprim data are being presented at the 28th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2019) in Amsterdam, The Netherlands.